These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36207873)

  • 1. [The application value of cardiac magnetic resonance quantitative T
    Wang Y; Lin L; Cao J; Li X; Wang J; Jing ZC; Jin ZY; Wang YN
    Zhonghua Yi Xue Za Zhi; 2022 Oct; 102(37):2963-2968. PubMed ID: 36207873
    [No Abstract]   [Full Text] [Related]  

  • 2. Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension.
    Sree Raman K; Shah R; Stokes M; Walls A; Woodman RJ; Perry R; Walker JG; Proudman S; De Pasquale CG; Celermajer DS; Selvanayagam JB
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):22. PubMed ID: 33678188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased native T1-values at the interventricular insertion regions in precapillary pulmonary hypertension.
    Spruijt OA; Vissers L; Bogaard HJ; Hofman MB; Vonk-Noordegraaf A; Marcus JT
    Int J Cardiovasc Imaging; 2016 Mar; 32(3):451-9. PubMed ID: 26472581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial Hypertension.
    Celant LR; Wessels JN; Marcus JT; Meijboom LJ; Bogaard HJ; de Man FS; Vonk Noordegraaf A
    Chest; 2024 Jan; 165(1):181-191. PubMed ID: 37527773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial T1-mapping and extracellular volume in pulmonary arterial hypertension: A systematic review and meta-analysis.
    Alabed S; Saunders L; Garg P; Shahin Y; Alandejani F; Rolf A; Puntmann VO; Nagel E; Wild JM; Kiely DG; Swift AJ
    Magn Reson Imaging; 2021 Jun; 79():66-75. PubMed ID: 33745961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension.
    Asano R; Ogo T; Morita Y; Kotoku A; Aoki T; Hirakawa K; Nakayama S; Ueda J; Tsuji A; Waddingham MT; Ohta Y; Fukuda T; Ohta-Ogo K; Ishibashi-Ueda H; Noguchi T; Yasuda S
    PLoS One; 2021; 16(11):e0260456. PubMed ID: 34843578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Hepatic Native T1 and Extracellular Volume Fraction in Patients with Pulmonary Arterial Hypertension.
    Guo J; Wang L; Wang J; Wan K; Gong C; Chen X; Guo J; Xu Y; He J; Yin L; Pu S; Wen B; Chen C; Han Y; Chen Y
    J Am Heart Assoc; 2022 Nov; 11(22):e026254. PubMed ID: 36346060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic significance of cardiovascular magnetic resonance native myocardial T1 mapping in patients with pulmonary hypertension.
    Saunders LC; Johns CS; Stewart NJ; Oram CJE; Capener DA; Puntmann VO; Elliot CA; Condliffe RC; Kiely DG; Graves MJ; Wild JM; Swift AJ
    J Cardiovasc Magn Reson; 2018 Dec; 20(1):78. PubMed ID: 30501639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.
    Xu H; Peng W; Yang Z; Zhang Y; Xia C; Li Z; Xu R; Guo Y
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):23. PubMed ID: 33691727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncontrast Myocardial T1 Mapping by Cardiac Magnetic Resonance Predicts Outcome in Patients With Aortic Stenosis.
    Lee H; Park JB; Yoon YE; Park EA; Kim HK; Lee W; Kim YJ; Cho GY; Sohn DW; Greiser A; Lee SP
    JACC Cardiovasc Imaging; 2018 Jul; 11(7):974-983. PubMed ID: 29153562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Myocardial Fibrosis, Atrophy, and Impaired Contractility in Patients With Pulmonary Arterial Hypertension and a Preserved Left Ventricular Function: A Cardiac Magnetic Resonance Study.
    Homsi R; Luetkens JA; Skowasch D; Pizarro C; Sprinkart AM; Gieseke J; Meyer Zur Heide Gen Meyer-Arend J; Schild HH; Naehle CP
    J Thorac Imaging; 2017 Jan; 32(1):36-42. PubMed ID: 27861208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, segmental and layer specific analysis of myocardial involvement in Duchenne muscular dystrophy by cardiovascular magnetic resonance native T1 mapping.
    Xu K; Xu HY; Xu R; Xie LJ; Yang ZG; Yu L; Zhou B; Fu H; Liu H; Cai XT; Guo YK
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):110. PubMed ID: 34645467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
    Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.
    Lewis RA; Johns CS; Cogliano M; Capener D; Tubman E; Elliot CA; Charalampopoulos A; Sabroe I; Thompson AAR; Billings CG; Hamilton N; Baster K; Laud PJ; Hickey PM; Middleton J; Armstrong IJ; Hurdman JA; Lawrie A; Rothman AMK; Wild JM; Condliffe R; Swift AJ; Kiely DG
    Am J Respir Crit Care Med; 2020 Feb; 201(4):458-468. PubMed ID: 31647310
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
    Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
    BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on native T
    Hu P; Zhou H; Tang H; Li W; Zhou M; Chen R; Zhou G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):1003-1009. PubMed ID: 34707011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular magnetic resonance in heart transplant patients: diagnostic value of quantitative tissue markers: T2 mapping and extracellular volume fraction, for acute rejection diagnosis.
    Vermes E; Pantaléon C; Auvet A; Cazeneuve N; Machet MC; Delhommais A; Bourguignon T; Aupart M; Brunereau L
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):59. PubMed ID: 30153847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric cardiovascular magnetic resonance imaging in acute myocarditis: a comparison of different measurement approaches.
    Dabir D; Vollbrecht TM; Luetkens JA; Kuetting DLR; Isaak A; Feisst A; Fimmers R; Sprinkart AM; Schild HH; Thomas D
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):54. PubMed ID: 31462282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.